Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...
Scientists have successfully created immature human egg-like cells from skin-derived stem cells, a significant step in ...
Cathy Tie, who launched her first biotech in SF's IndieBio, now leads Manhattan Genomics in controversial push to edit human ...
Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...
In a nascent and fragmented regulatory environment, focusing on the ethical implications of the company’s AI activities is a prudent strategy for board oversight of AI risk.
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the ...
Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...
The Boston biotech founded by Harvard professor David Sinclair is testing whether cellular reprogramming can turn back the ...
Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...
Ectogenesis could transform reproduction, but Assistant Professor Susan Kennedy believes that choosing to carry a child can still hold deep personal and moral significance ...
Gene editing techniques, including CRISPR, prime editing, and nucleases, allow scientists to tackle genetic diseases, cancer, ...
The Festival of Genomics and Biodata is just around the corner, and we’ve had the opportunity to sit down with […] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback